Synthetic drug methiopropamine (MPA) to be placed under Class B

Methiopropamine (MPA) – a synthetic drug which is similar in structure to amphetamine and formerly often marketed as a ‘legal alternative’ to cocaine – is to be placed as a Class B drug following guidance from the Advisory Council on the Misuse of Drugs (ACMD).

The ACMD’s advice concerned an apparent increase in the harms associated with the use of MPA, particularly related to its potential intravenous injection.

The ACMD has recommended that MPA, currently subject to a Temporary Class Drug Order (TCDO) until the 27th of November, is placed in Class B of the Misuse of Drugs Act 1971 (as amended) and Schedule 1 of the Misuse of Drugs Regulations 2001 (as amended), as no legitimate medicinal use of the substance has been found.

Sarah Newton MP, Minister for Vulnerability, Safeguarding and Countering Extremism has written to the ACMD accepting the advice and has stated that work will now commence to ensure that the necessary controls are in place before the end of the current TCDO.

Click here to read the ACMD report ‘Methiopropamine (MPA): A review of the evidence of use and harm’